Skip to content
ECPC - European Cancer Patient Coalition
Contact
  • Policy
    • Innovation
      • Access to Medicines
      • Europe of Disparities in Cancer Care
      • Molecular Testing & Personalised Medicine
      • Biosimilars
      • Immuno-Oncology
    • Health Technology Assessment
      • HTA Legislation
    • Public Health Policies
      • European Partnership for Action Against Cancer (EPAAC)
      • Joint Action on Cancer Control (CanCon)
      • iPAAC
      • Vaccines
      • Brexit
    • Societal Issues
      • Cancer Patients’ Rights
      • Employment
      • Survivorship
      • Carers
      • Right to Be Forgotten
    • Quality of Care
      • Cancer Comorbidities
      • All.Can
      • BenchCan
      • Nutrition
      • Specific Cancers
    • Rare Cancers
      • JARC
      • EURACAN
      • RARECARENet
  • Health and Research
    • Big Data and Personalised Medicine
      • BD4BO DO-IT
      • BD4BO PIONEER
      • LEGACy
      • PREDICT
      • EUCANCan
      • Instand-NGS4P
      • INTERVENE
      • T2EVOLVE
      • QUALITOP
      • TIGER
    • Knowledge Sharing Networks
      • HTx
      • EurocanPlatform
      • ELBA
      • TRANSCAN-2
    • Patients and Caregivers
      • DIAdIC
      • eSMART
      • PREFER
      • Lifechamps
    • Palliative Care
      • Palliative Sedation
      • InSup-C
    • Treatments
      • Immune-Image
      • DENIM
      • ImmunoSABR
  • Get Involved
    • Membership
    • Campaigns
      • Bladder Cancer Awareness Month Campaign
      • Head and Neck Cancer Campaigns 2021
      • Nutrition and Physical Activity
      • Pancreatic Cancer ‘World Pancreatic Cancer Day’ Campaign
      • Personalised Medicine Awareness Month
      • Non Melanoma Skin Cancer Campaign
      • Merkel Cell Carcinoma Awareness Campaign
      • Merkel Cell Carcinoma 2020 Awareness Campaign
      • Breast Cancer
    • Working Groups
      • Rare Cancers Working Group
      • Urological Cancer Working Group
      • The Legal Network for Cancer Patients
    • Partnerships
      • Funding Policy and Good Practices
      • European Medicines Agency
      • Collaborations
      • Graphic Design Kit
    • Industry Supporters
  • TOOLBOX
    • Tools
      • Biobanking
      • Bone Health
      • Clinical Trials Database
      • ESMO Cancer Patient Guides
      • Nutrition Booklet
      • The Immuno-oncology Portal (IOP)
      • Personalised Medicine
      • Non-Melanoma Skin Cancer Web Hub
      • Merkel Cell Carcinoma
      • Cancer Associated Thrombosis (CAT)
      • Health Technology Assessment E-Module
      • Social Media Manual, Cancer Advocacy Academy
      • Biosimilars E-module
      • Genetics and Genomics Testing – A guide for patients E-module
    • References
      • White Papers
      • EU Funded Programmes
    • Publications
    • Resources
  • News and Events
    • News
    • Elections
    • Conference and General Meeting
    • Events
    • Newsletters
  • About us
    • Our Strategy
    • Our Team
    • Members
    • Vacancies
    • Our History
    • Mission and Vision
    • Transparency
  • COVID-19 Information
  • Intergroup
Contact

20 Million Reasons to Discuss Life After Cancer: Establishing a European Survivorship Day

An EU Cancer Survivorship Day becoming a reality

Last year, ECPC’s event on life after cancer and putting an end to discrimination helped to raise awareness of cancer survivorship issues in the EU and called for the formalisation of a European Cancer Survivors Day.

This year, our webinar seeks to provide an impetus for the formal establishment of an annual EU Cancer Survivorship Day, following the example of several national cancer survivorship days which bring together communities worldwide to recognise survivors and the challenges they face and celebrate life after cancer. The Challenge Cancer Intergroup is committed to making the creation of an EU cancer survivors day become a reality.

Register for the webinar hosted on the 29th June from 10:30 to 11:30.

You can download the agenda here.

PROGRAMME

10:30 – 10:35 | Introduction and opening remarks
Prof. Dr. Mark Lawler, Professor of Digital Health, Faculty of Medicine, Queen’s University Belfast and ECPC Scientific Committee Member
10:35 – 10:45 | Understanding and prioritising the needs of cancer survivors
MEP Cristian Silviu Bușoi (EPP, Romania), Chair of Challenge Cancer Parliamentary Intergroup
Dr. Roberta De Angelis, Senior Researcher, Director of Cancer Epidemiology and Genetics Unit, Italian National Institute of Health
10:45 – 11:00 | Implementing return to work policies for cancer survivors
Discussion panel
Magali Mertens de Wilmars, Founder of Work&Cancer
Barbara Wilson, Founder and Director of Working with Cancer
Stephen Bevan, Head, HR Research Development, Institute for Employment Studies
11:00 – 11:10 | Q&A

11:10 – 11:25 | Towards a European cancer survivors day: next steps
Stella Kyriakides, European Commissioner for Health and Food Safety
MEP Romana Jerković (S&D, Croatia), Member of the Challenge Cancer Intergroup
11:25 – 11:30 | Concluding remarks
Ken Mastris, ECPC President
Moderated by Prof. Dr. Mark Lawler

< Back to Events

Donate

x

The fight against cancer is not just for patients, it is vital that we work together.

Your support is greatly appreciated!  Donate now

What happens to your donation?

We understand that when you make a donation, you want to know exactly what happens to your money. We aim to be clear and transparent when it comes to using your contributions in our mission to fight cancer. Your donations not only help us to empower the cancer patient community and make a positive difference to healthcare, treatment and accessibility, but also enable us to:
  • ensure our members are engaged and feel part of an active community through information, training, unique resources, tools, opportunities and networking at a national and European level
  • legitimise our position of cancer patient representatives before decision-makers
  • build a reputation as a cancer patient expert within the scientific community
  • find partners sharing the same vision, values and goals to work together on projects
  • get the media’s attention in order to publish and disseminate our messages
  • make the general public aware and supportive

Subscribe to our newsletter

x

Subscribe

* indicates required

By clicking on the button below I expressly confirm that I have read and understood ECPC Privacy Policy http://ow.ly/i94050BPZx0

For more information on ECPC's policies visit our website http://ow.ly/8XCj50BQasP

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Connect with us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Youtube

© ECPC 2022. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
  • Cookie Policy of the of ECPC AISBL